Semaglutide and the Immune System: What We Know So Far

Semaglutide is a GLP-1 receptor agonist — it mimics a gut hormone involved in appetite regulation and blood-sugar control, not a hormone that governs immune function directly.
Clinical trial data from the STEP programme did not identify immune suppression as a side effect; the most commonly reported side effects are gastrointestinal (nausea, diarrhoea, constipation).
Emerging research suggests GLP-1 receptors are present on some immune cells, meaning semaglutide may have indirect effects on inflammation, a field that is still being studied.
Anyone with an active infection, a condition affecting their immune system, or taking immunosuppressant medicines should discuss this with their prescriber before starting treatment.

Semaglutide does not suppress the immune system in the way that immunosuppressant drugs do, and there is no clinical evidence that Wegovy weakens your body's ability to fight infection. What research is beginning to explore is more nuanced: semaglutide may interact with certain immune and inflammatory processes as a secondary effect of how it works — and for most people taking it for weight management, that picture looks broadly neutral or potentially positive. These are prescription-only medicines, reviewed by a clinical prescriber before they are issued; your own health history is always part of that assessment. The sections below walk through what the current evidence actually says, step by step, so you can have a more informed conversation with your prescriber.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How semaglutide interacts with immune and inflammatory pathways, and what that means for you

Step 1: Understanding what semaglutide actually does in the body

Semaglutide works by activating GLP-1 receptors, which are found in the gut, pancreas and brain. Activating these receptors slows gastric emptying, reduces appetite and helps regulate blood sugar. You can read a full overview of the medicine on the semaglutide page, but the key point here is that GLP-1 receptors are not part of the immune system's command structure. Semaglutide is not an immunosuppressant, a corticosteroid or a biologic drug of the kind used to treat autoimmune conditions. It does not directly interfere with T-cell function, antibody production or white blood cell counts.

That matters, because a common version of this question runs along the lines of: "will Wegovy make me more likely to catch infections?" The honest answer, based on the data we have, is that there is no established evidence it will. The large STEP 1 trial, published in the New England Journal of Medicine, did not flag immune suppression among the adverse effects recorded across 68 weeks of treatment. Infections were monitored and were not disproportionately elevated in the semaglutide group.

What is emerging, though, is a more interesting story about GLP-1 receptors appearing on certain immune cells, including macrophages and T-cells, and if you are wondering whether repeated exposure could change how well the medicine works, the page on whether you can become immune to semaglutide explores that question in detail. That does not mean semaglutide targets them, it means scientists are asking whether there are secondary effects, and the evidence is preliminary.

Step 2: What the research on inflammation and immune cells is actually finding

A question our prescribers hear most weeks is whether Wegovy could affect existing inflammatory conditions (arthritis, thyroid disease, skin conditions) or interfere with the immune system in subtler ways. It is a fair question, and the honest answer involves two tiers of evidence.

The first tier is clinical trial data: large, well-controlled studies have not shown that semaglutide impairs immune function. The NHS tirzepatide and semaglutide medicines pages list the known side effects clearly, they are dominated by GI symptoms, not infection risk or immune events.

The second tier is early-stage research. Some laboratory and small-scale studies suggest GLP-1 receptor activation may reduce markers of inflammation, which could in theory benefit people with chronic inflammatory conditions. Obesity itself is a pro-inflammatory state, so some researchers hypothesise that the weight loss produced by semaglutide may lower systemic inflammation indirectly. This is plausible, but it is not yet established clinical fact, and it has not translated into specific guidance for patients with autoimmune conditions. If you have such a condition, this is a conversation for your prescriber and the specialist managing that condition, not something to extrapolate from population-level trial data.

For a more detailed look at whether the evidence points to any weakening effect, the page on whether Wegovy can weaken your immune system addresses that specific concern directly.

Step 3: Situations where immune health and semaglutide genuinely need prescriber input

There are scenarios where the interaction between semaglutide and immune health deserves proper clinical attention, not because Wegovy is necessarily contraindicated, but because the full picture matters.

If you are taking immunosuppressant medicines (for example after an organ transplant, or to manage a condition like Crohn's disease or lupus) the conversation about adding any new medicine should happen with your prescribing team and your specialist. Semaglutide is not flagged as incompatible with immunosuppressants as a class, but there may be individual considerations, including GI side effects overlapping with symptoms of your underlying condition.

Oral contraceptive absorption can be reduced during the initial weeks of semaglutide use; a separate but related point about how GLP-1 medicines can affect how the gut absorbs other substances. The detailed page on whether semaglutide lowers immune function covers the absorption and drug-interaction angle in more depth. And if you are wondering how long the medicine's effects persist after stopping, the page on how long semaglutide stays in your system is a useful read.

Active infections are worth flagging too. Starting any new medicine during a significant infection is usually something to delay until you have recovered, this is straightforward clinical common sense, and a GPhC-registered prescriber at nume will ask about it during the consultation process. Our clinical team reviews every consultation personally before a prescription is issued.

Step 4: Putting it in context, what this means for your decision

The semaglutide and immune system question is one where the anxiety tends to outrun the evidence. Based on what we know from clinical trials and the NHS guidance on semaglutide, this medicine does not suppress immune function and is not associated with increased infection rates in the patient populations studied. The emerging science on GLP-1 receptors and inflammation is genuinely interesting, but it is early-stage and does not change current prescribing guidance.

If you have a pre-existing immune condition or take medicines that affect immune function, that is precisely the kind of detail a clinical prescriber needs to know, and is exactly what a thorough consultation is designed to surface. The question of how Wegovy affects the immune system more broadly, including in people with autoimmune conditions, sits within that clinical conversation. You can explore your treatment options and what a consultation involves on our weight-loss treatments page. If you have questions before you start, the FAQs cover a wide range of common concerns.

If you are ready to find out whether Wegovy is suitable for you, start your free consultation with our prescribers, and get a clinically reviewed answer specific to your health history, not a one-size answer from the internet.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions